Zelos' Series B Round Nets $42M For PTH Drug Pipeline May 19, 2005 By Jennifer Boggs Zelos Therapeutics Inc. raised $42.5 million in a Series B round to fund clinical trials of its next-generation parathyroid hormone (PTH) analogue in four indications. (BioWorld Today)Read More
RSS